{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Efficacy of Inhaled Nitric Oxide in Preterm Neonates

Activity Steps

Purpose of Activity

To provide registered professional nurses with an understanding of the efficacy and safety of inhaled nitrous oxide (iNO) therapy in preterm infants with severe respiratory distress syndrome (RDS) and respiratory failure.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Define the pathology of RDS and the physiological effects of iNO.
  2. Outline the effects of iNO on infants' neurodevelopmental status.
  3. Review the results of studies demonstrating the efficacy of iNO.
Price: $21.95

Credits:

  • ANCC 2.3 CH
  • DC - BON 2.3 CH
  • KY-BON 2.0 CH

Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
--------------------------------------------------
This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia and Florida #50-1223. Your certificate is valid in all states.
--------------------------------------------------
The ANCC's accreditation status of Lippincott Williams & Wilkins Department of Continuing Education refers only to its continuing nursing educational activities and does not imply Commission on Accreditation approval or endorsement of any commercial product.





Test Code: ANC0112
Published: February 2012
Expires: 12/31/2026
Required Passing Score: 13/18 (72%)
Authors: Lauren E. Love MSN, RN, CNS, NNP-BC, Wanda T. Bradshaw MSN, RN, NNP-BC, Ksenia Zukowsky
Categories: Neonatal
Specialties: Maternal-Child